Xianyu Zhang

机构：Shangrao Normal University, Harbin Medical University, Third Affiliated Hospital of Harbin Medical University · ORCID：0000-0002-9738-2361

发表论文 94 篇 · 总被引 1638 次 · h-index 22

代表论文

• Taletrectinib in ROS1 + Non–Small Cell Lung Cancer: TRUST (2025 · Journal of Clinical Oncology · 被引 54)
• Liraglutide, a glucagon-like peptide-1 receptor agonist, ameliorates inflammation and apoptosis via inhibition of receptor for advanced glycation end products signaling in AGEs induced chondrocytes (2024 · BMC Musculoskeletal Disorders · 被引 33)
• HLAIImaster: a deep learning method with adaptive domain knowledge predicts HLA II neoepitope immunogenic responses (2024 · Briefings in Bioinformatics · 被引 18)
• Meta learning for mutant HLA class I epitope immunogenicity prediction to accelerate cancer clinical immunotherapy (2024 · Briefings in Bioinformatics · 被引 13)
• Engineered crRNA Drives RPA‐T7‐CRISPR/Cas14a Cascade for Ultrasensitive Detection of ctDNA PIK3CA H1047R (2025 · Advanced Science · 被引 11)
• Tofacitinib to prevent anti-drug antibody formation against LMB-100 immunotoxin in patients with advanced mesothelin-expressing cancers (2024 · Frontiers in Oncology · 被引 9)